For patients without heart disease, addressing obesity early can help prevent future complications
Methods Trial design and participants This phase 3, randomized, double-blind, placebo-controlled study was conducted at 41 sites across five countries (Canada, Italy, Hungary, Spain and the United States), as described in a previous publication 8 and listed in the Supplementary information
Patients with repeated hypoglycemic episodes can develop hypoglycemia unawareness
0.25mg weekly), then titrate gradually per standard schedule, regardless of the previous tirzepatide dose
To address these inequities, policymakers should invest in programs to eliminate systemic inequities in healthcare